Phunware Competitors

Phunware (NASDAQ:PHUN) and Ooma (NYSE:OOMA) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Valuation and Earnings

This table compares Phunware and Ooma's gross revenue, earnings per share (EPS) and valuation.

Phunware has higher earnings, but lower revenue than Ooma. Ooma is trading at a lower price-to-earnings ratio than Phunware, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Phunware and Ooma's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and recommmendations for Phunware and Ooma, as reported by MarketBeat.

Phunware currently has a consensus price target of $4.00, indicating a potential upside of 173.97%. Ooma has a consensus price target of $22.8750, indicating a potential upside of 40.25%. Given Phunware's higher possible upside, equities analysts plainly believe Phunware is more favorable than Ooma.

Institutional & Insider Ownership

4.1% of Phunware shares are held by institutional investors. Comparatively, 75.8% of Ooma shares are held by institutional investors. 13.6% of Phunware shares are held by company insiders. Comparatively, 10.2% of Ooma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

Phunware has a beta of 12.85, meaning that its stock price is 1,185% more volatile than the S&P 500. Comparatively, Ooma has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500.

Liberty TripAdvisor (NASDAQ:LTRPA) and Phunware (NASDAQ:PHUN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Liberty TripAdvisor and Phunware, as provided by MarketBeat.com.

Phunware has a consensus price target of $4.00, indicating a potential upside of 173.97%. Given Phunware's higher probable upside, analysts clearly believe Phunware is more favorable than Liberty TripAdvisor.

Risk & Volatility

Liberty TripAdvisor has a beta of 2.62, suggesting that its share price is 162% more volatile than the S&P 500. Comparatively, Phunware has a beta of 12.85, suggesting that its share price is 1,185% more volatile than the S&P 500.

Valuation and Earnings

This table compares Liberty TripAdvisor and Phunware's revenue, earnings per share and valuation.

Phunware has lower revenue, but higher earnings than Liberty TripAdvisor.

Insider and Institutional Ownership

72.0% of Liberty TripAdvisor shares are held by institutional investors. Comparatively, 4.1% of Phunware shares are held by institutional investors. 6.8% of Liberty TripAdvisor shares are held by insiders. Comparatively, 13.6% of Phunware shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Liberty TripAdvisor and Phunware's net margins, return on equity and return on assets.

Phunware (NASDAQ:PHUN) and Leaf Group (NYSE:LEAF) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Volatility & Risk

Phunware has a beta of 12.85, suggesting that its share price is 1,185% more volatile than the S&P 500. Comparatively, Leaf Group has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500.

Insider & Institutional Ownership

4.1% of Phunware shares are held by institutional investors. Comparatively, 68.4% of Leaf Group shares are held by institutional investors. 13.6% of Phunware shares are held by company insiders. Comparatively, 11.4% of Leaf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Phunware and Leaf Group, as reported by MarketBeat.

Phunware currently has a consensus price target of $4.00, suggesting a potential upside of 173.97%. Leaf Group has a consensus price target of $9.00, suggesting a potential upside of 3.21%. Given Phunware's higher probable upside, equities analysts clearly believe Phunware is more favorable than Leaf Group.

Earnings and Valuation

This table compares Phunware and Leaf Group's gross revenue, earnings per share (EPS) and valuation.

Phunware has higher earnings, but lower revenue than Leaf Group.

Profitability

This table compares Phunware and Leaf Group's net margins, return on equity and return on assets.

Summary

Leaf Group beats Phunware on 7 of the 13 factors compared between the two stocks.

Castlight Health (NYSE:CSLT) and Phunware (NASDAQ:PHUN) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Profitability

This table compares Castlight Health and Phunware's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Castlight Health and Phunware, as reported by MarketBeat.

Castlight Health currently has a consensus price target of $1.3750, indicating a potential downside of 29.49%. Phunware has a consensus price target of $4.00, indicating a potential upside of 173.97%. Given Phunware's stronger consensus rating and higher possible upside, analysts clearly believe Phunware is more favorable than Castlight Health.

Volatility and Risk

Castlight Health has a beta of 1.88, indicating that its stock price is 88% more volatile than the S&P 500. Comparatively, Phunware has a beta of 12.85, indicating that its stock price is 1,185% more volatile than the S&P 500.

Insider and Institutional Ownership

46.2% of Castlight Health shares are owned by institutional investors. Comparatively, 4.1% of Phunware shares are owned by institutional investors. 17.1% of Castlight Health shares are owned by company insiders. Comparatively, 13.6% of Phunware shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Castlight Health and Phunware's gross revenue, earnings per share and valuation.

Phunware has lower revenue, but higher earnings than Castlight Health. Castlight Health is trading at a lower price-to-earnings ratio than Phunware, indicating that it is currently the more affordable of the two stocks.

Phunware (NASDAQ:PHUN) and NantHealth (NASDAQ:NH) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Phunware and NantHealth's net margins, return on equity and return on assets.

Insider & Institutional Ownership

4.1% of Phunware shares are held by institutional investors. Comparatively, 5.5% of NantHealth shares are held by institutional investors. 13.6% of Phunware shares are held by insiders. Comparatively, 59.6% of NantHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings for Phunware and NantHealth, as reported by MarketBeat.

Phunware presently has a consensus target price of $4.00, indicating a potential upside of 173.97%. Given Phunware's higher possible upside, research analysts plainly believe Phunware is more favorable than NantHealth.

Volatility and Risk

Phunware has a beta of 12.85, meaning that its share price is 1,185% more volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500.

Earnings & Valuation

This table compares Phunware and NantHealth's revenue, earnings per share (EPS) and valuation.

Phunware has higher earnings, but lower revenue than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than Phunware, indicating that it is currently the more affordable of the two stocks.

Summary

Phunware beats NantHealth on 7 of the 13 factors compared between the two stocks.

Phunware (NASDAQ:PHUN) and BlueCity (NASDAQ:BLCT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Institutional and Insider Ownership

4.1% of Phunware shares are owned by institutional investors. Comparatively, 2.0% of BlueCity shares are owned by institutional investors. 13.6% of Phunware shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Phunware and BlueCity's revenue, earnings per share and valuation.

BlueCity has higher revenue and earnings than Phunware.

Profitability

This table compares Phunware and BlueCity's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings for Phunware and BlueCity, as provided by MarketBeat.

Phunware currently has a consensus target price of $4.00, indicating a potential upside of 173.97%. BlueCity has a consensus target price of $20.00, indicating a potential upside of 156.41%. Given Phunware's higher probable upside, analysts plainly believe Phunware is more favorable than BlueCity.

Summary

BlueCity beats Phunware on 6 of the 10 factors compared between the two stocks.